Boston Scientific lands $71m Defense Dept. contract

The U.S. Defense Dept. said yesterday that it awarded a contract worth $71 million to Boston Scientific (NYSE:BSX).

The agreement calls for Marlborough, Mass.-based Boston Scientific to provide cardiovascular products to the U.S. Army, Navy, Air Force, Marine Corps and federal civilian agencies. The deal has a 1-year base contract with 4 1-year renewal options, according to the Defense Dept.

Earlier this week, Boston Scientific agreed to pay $210 million for EndoChoice (NYSE:GI) and its line of devices for treating gastrointestinal disease.

The $8-per-share offer is slated to close by the end of the year, the companies said. EndoChoice took itself public in June 2015 with an IPO that brought in some $96 million.

The post Boston Scientific lands $71m Defense Dept. contract appeared first on MassDevice.

from MassDevice http://ift.tt/2dshxMu